MPRS Stock Chart & Stats
55.50
0.01(1.61%)
At close: 4:00 PM EST
55.50
0.01(1.61%)
Day’s Range― - ―
52-Week Range43.40 - 75.70
Previous CloseN/A
Volume459.00
Average Volume (3M)2.43K
Market Cap
₪8.33M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.36
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,012,000
10 Day Avg. Volume0
30 Day Avg. Volume2,430
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mediprss Pu News
MPRS FAQ
What was Mediprss Pu’s price range in the past 12 months?
Mediprss Pu lowest stock price was 43.40 and its highest was 75.70 in the past 12 months.
What is Mediprss Pu’s market cap?
Mediprss Pu’s market cap is ₪8.33M.
When is Mediprss Pu’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mediprss Pu’s earnings last quarter?
Currently, no data Available
Is Mediprss Pu overvalued?
According to Wall Street analysts Mediprss Pu’s price is currently Overvalued.
Does Mediprss Pu pay dividends?
Mediprss Pu does not currently pay dividends.
What is Mediprss Pu’s EPS estimate?
Mediprss Pu’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mediprss Pu have?
Mediprss Pu has 15,012,000 shares outstanding.
What happened to Mediprss Pu’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mediprss Pu?
Currently, no hedge funds are holding shares in IL:MPRS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mediprss Pu
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.